Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
Abstract Shiga toxin (Stx)-induced hemolytic uremic syndrome (HUS) poses a life-threatening complication for which a definitive treatment remains elusive. To exert its cytotoxic effect on renal cells, Stx must be delivered from the infected intestines to the kidney. However, the mechanism underlying...
Saved in:
Main Authors: | Xinlei Sun, Shuang Qu, Fenglian Zhou, Fujie Shi, Yunfei Wu, Lin Gu, Minghui Liu, Zhen Bian, Lei Shi, Zhihong Liu, Yuan Liu, Ke Zen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Cellular & Molecular Biology Letters |
Subjects: | |
Online Access: | https://doi.org/10.1186/s11658-025-00689-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical Hemolytic Uremic Syndrome with Eosinophilia and Purtscher-like Retinopathy: A Case Report
by: MEI Qimin, et al.
Published: (2024-12-01) -
Metabolomics to Identify Unclassified Uremic Toxins: A Comprehensive Literature Review
by: Raymond Vanholder, et al.
Published: (2025-03-01) -
Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease
by: M. O. Pyatchenkov, et al.
Published: (2023-09-01) -
Hemodiafiltration with endogenous reinfusion for uremic toxin removal in patients undergoing maintenance hemodialysis: a pilot study
by: Renhua Lu, et al.
Published: (2024-12-01) -
Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders
by: Shihan Zhang, et al.
Published: (2025-01-01)